Please try another search
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Name | Age | Since | Title |
---|---|---|---|
Robert Hayman | 64 | 2018 | Independent Director |
Simone Blank | 60 | 2018 | Director |
Karah Herdman Parschauer | 46 | 2019 | Independent Director |
Vikram Malik | 61 | 2018 | Chairman of the Board |
David N. Gill | 69 | 2018 | Independent Director |
Brady Stewart | 48 | 2022 | Independent Director |
David Moatazedi | 46 | 2018 | President, CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review